Medtronic’s pulsed field ablation device meets safety, efficacy metrics in trial

Medtronic’s device didn’t outperform competing systems being developed by J&J and Boston Scientific, but the results should be enough to secure FDA approval, one analyst wrote.

Scroll to Top